About
surface oncology was created to advance next‐generation approaches to cancer immunotherapy based on proprietary insights about novel immunotherapy targets and emerging areas of cancer immuno‐biology. the company’s scientific founders and sab are comprised
CEOJ. Jeffrey Goater
HQCambridge, Massachusetts
Employees90